Clinical Trials Logo

Clinical Trial Summary

Recently, many gynecologic oncologists proposed that surgeons should consider opportunistic salpingectomy to prevent ovarian cancer for all patients undergoing hysterectomy for benign disease. However, the safety and the consequences regarding ovarian function after salpingectomy have not yet to be established. Therefore, the aim of this randomized controlled study is compare the ovarian reserve via anti-Müllerian hormone (AMH) between laparoscopic hysterectomy (LH) alone and LH combined with salpingectomy.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01893086
Study type Interventional
Source CHA University
Contact
Status Completed
Phase Phase 3
Start date June 2013
Completion date July 2015

See also
  Status Clinical Trial Phase
Active, not recruiting NCT01683890 - Study on Bladder and Sexual Function Change After Simple Hysterectomy N/A
Completed NCT01880710 - Total Versus Subtotal Abdominal Hysterectomy N/A
Completed NCT01217866 - A Retrospective Review of Enseal Laparoscopic Vaginal Assisted Hysterectomy (LAVH) Versus Traditional LAVH N/A
Completed NCT01861067 - LESS-TLH Versus LESS-LAVH Phase 3